Literature DB >> 21900395

IRF-1 expression is essential for natural killer cells to suppress metastasis.

Antje Ksienzyk1, Berit Neumann, Ramya Nandakumar, Katja Finsterbusch, Martina Grashoff, Rainer Zawatzky, Günter Bernhardt, Hansjörg Hauser, Andrea Kröger.   

Abstract

IFN-γ promotes tumoral immune surveillance, but its involvement in controlling metastases is less clear. Using a mouse model of pulmonary metastases, we show that local IFN-γ treatment inhibits formation of metastases through its regulation of IRF-1 in tumor cells. IRF-1 is an IFN-γ-induced transcription factor pivotal in the regulation of infection and inflammation. IRF-1 blockade abolished the inhibitory effect of IFN-γ on tumor metastases, whereas ectopic expression of IRF-1 phenocopied the inhibitory effects of IFN-γ. IRF-1 did not affect the survival of tumor cells in the circulation or their infiltration into lungs, but it was essential to support the pulmonary attraction and activation of natural killer (NK) cells. Depleting NK cells from mice abolished the protective effect of IFN-γ or IRF-1 on metastases. In addition, cytotoxicity assays revealed that tumor cells expressing IRF-1 were targeted more effectively by NK cells than IRF-1 nonexpressing tumor cells. Moreover, NK cells isolated from lungs inoculated with IRF-1-expressing tumor cells exhibit a greater cytotoxic activity. Mechanistic investigations revealed that IRF-1-induced NK cell cytotoxicity was independent of perforin and granzyme B but dependent on the NK cell activating receptor DNAM-1. Taken together, our findings establish IRF-1 as an essential mediator of the cross-talk between tumor cells and NK cells that mediate immune surveillance in the metastatic niche.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900395     DOI: 10.1158/0008-5472.CAN-11-1565

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis.

Authors:  Yung-Chieh Chan; Yu-Chan Chang; Hsiang-Hao Chuang; Yi-Chieh Yang; Yuan-Feng Lin; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang; Kuo-Tai Hua
Journal:  Oncogene       Date:  2020-01-27       Impact factor: 9.867

2.  Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.

Authors:  Kelly C G ManfrereC; Marina P Torrealba; Denis R Miyashiro; Nátalli Z Pereira; Fabio S Y Yoshikawa; Luana de M Oliveira; Jade Cury-Martins; Alberto J S Duarte; José A Sanches; Maria N Sato
Journal:  Oncotarget       Date:  2017-09-18

3.  Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.

Authors:  Craig M Brackett; Bojidar Kojouharov; Jean Veith; Kellee F Greene; Lyudmila G Burdelya; Sandra O Gollnick; Scott I Abrams; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

4.  IRF-1 is critical for IFNγ mediated immune surveillance.

Authors:  Antje Ksienzyk; Berit Neumann; Andrea Kröger
Journal:  Oncoimmunology       Date:  2012-07-01       Impact factor: 8.110

5.  Natural killer cells: role in local tumor growth and metastasis.

Authors:  Inge Langers; Virginie M Renoux; Marc Thiry; Philippe Delvenne; Nathalie Jacobs
Journal:  Biologics       Date:  2012-04-05

6.  Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes.

Authors:  John Ammori; Khaled Hamzeh; Hallie Graor; Julian Kim
Journal:  J Immunol Res       Date:  2015-06-10       Impact factor: 4.818

7.  Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response.

Authors:  I Eckhardt; A Weigert; S Fulda
Journal:  Cell Death Dis       Date:  2014-12-11       Impact factor: 8.469

8.  Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.

Authors:  Ilona Hromadnikova; Petra Pirkova; Lucie Sedlackova
Journal:  Mediators Inflamm       Date:  2013-02-17       Impact factor: 4.711

9.  Natural killer cells in non-hematopoietic malignancies.

Authors:  Mélanie Desbois; Sylvie Rusakiewicz; Clara Locher; Laurence Zitvogel; Nathalie Chaput
Journal:  Front Immunol       Date:  2012-12-24       Impact factor: 7.561

10.  Regulatory Snapshots: integrative mining of regulatory modules from expression time series and regulatory networks.

Authors:  Joana P Gonçalves; Ricardo S Aires; Alexandre P Francisco; Sara C Madeira
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.